NanoString’s CosMx SMI Achieved Whole Transcriptome Imaging At Single-Cell Resolution

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager (SMI). The data will be highlighted at the 42nd annual J.P. Morgan Healthcare Conference 2024 in San Francisco during NanoString’s corporate presentation on Wednesday, January 10, 2024, at 5:15 pm ET.

CosMx Whole Transcriptome Panel Achieves Scientific Moonshot

NanoString is the first company to achieve the scientific breakthrough of providing true single-cell whole transcriptome imaging. This technological milestone was accomplished using the CosMx SMI platform allowing researchers to simultaneously visualize the expression of every protein-coding gene in the human genome in situ, providing the ultimate capability for single cell spatial biology.

Total
0
Shares
Related Posts
Read More

Investor Sentiment Improves After Dow Gains For 10th Straight Session

The CNN Money Fear and Greed index showed some improvement in overall sentiment among U.S. investors on Friday. The Dow Jones recorded gains for a tenth straight session as traders assessed recent corporate earnings reports. On a weekly basis, the Dow rose 2.08%, while the S&P 500 added 0.69%, with both indices recording second positive week in a row.

AXP